Published15 October 2026, 00:01 BST
Women have been warned against self-medicating to manage menopause symptoms amid a shortage of some Hormone Replacement Therapy (HRT) medications.
Pharmacist Paul Irvine said he understood that women were "concerned" but urged them to speak to their GP or local chemist who could advise them about alternatives.
The warning follows official confirmation from the Department of Health (DoH) that supplies of two major HRT patch brands have been disrupted.
The affected products include Estradot transdermal and FemSeven Conti, both of which are currently facing manufacturing or distribution delays.
Irvine, a pharmacy manager in Belfast, said much of the time with HRT medications, women often become comfortable with a particular brand.
"When they are short and they like to try alternatives, they may suffer side effects or it might just not work as well," he said.
"So it is important for us as pharmacists that we are there to guide people and offer them alternatives and the correct advice."
'Real anxiety for patients'
Dr Ursula Mason, chair of the Royal College of General Practitioners Northern Ireland, said finding a substitute "can cause real anxiety for patients".
"This can be particularly so for HRT medication when a woman has found a preparation that works well for them," she said.
"Patients can be assured that the protocol in place only allows a substitution for exactly the same active ingredient at the same dose.
"If a woman finds that for whatever reason the new formulation is not managing their symptoms or they are having side effects, it would be important that they contact their GP to discuss both their symptoms and the options available around suitable alternatives."
The DoH said it was aware of "supply disruptions" affecting some HRT medications across the UK, including ongoing issues with Estradot transdermal patches and a more recent disruption affecting FemSeven Conti patches.
"Communications have been issued to healthcare professionals regarding the products affected, including advice on suitable alternatives that remain available," it said.
The department said serious shortage protocols (SSPs) for Estradot transdermal patches were currently in place until 8 January 2027.
This permits pharmacists to supply alternative products to patients without the need for a new prescription, where the patient has agreed.
"If patients cannot access their prescribed medication or have concerns about an alternative, they should speak to a healthcare professional for advice about their treatment options," a DoH spokesperson added.
Roisin Hillman, co-founder of Menopause Together, Northern Ireland's first menopause support charity, said some women forced to switch brands due to medication shortages had reported side effects like itchy skin or patches falling off.
She said that ongoing HRT patch shortages are deeply frustrating for women – and once they find a medication that works, it often falls in short supply.
"This is an issue going on for years," she said, advising women to request longer-term prescriptions from their GPs to stay ahead of supply gaps.
She also warned against sharing HRT with others.
"It is also really important that if you do have a shortage, and you can't get your normal HRT, to make sure you go back to your doctor," she said.
"Please do not share HRT with other women because what is prescribed to you may not suit someone else so it is very important that you go back to your GP."
Hillman said many women had "fear and anxiety" about shortages because "the HRT they are on is helping so many aspects of their life" and their mental health.
"If [a woman] is on HRT that works for her and then if she is not getting that HRT it can be really hard."
Hormone replacement therapy (HRT)
More coverage
Ex-DUP leader Donaldson to be sentenced for child sex abuse including rape
Gales and heavy rain to impact UK as yellow wind warning issued
Garvaghy Road residents fail in bid to challenge Drumcree decision
Discussion